Title: Screening for uterine tumours
Authors: Van den Bosch, Thierry ×
Coosemans, An
Morina, Memli
Timmerman, Dirk
Amant, Frédéric #
Issue Date: Apr-2012
Publisher: Baillière Tindall
Series Title: Best Practice & Research in Clinical Obstetrics & Gynaecology vol:26 issue:2 pages:257-66
Abstract: The most prevalent uterine tumours are leiomyomas, which are benign and have a prevalence of about 50% at menopause. The incidence of endometrial cancer and uterine sarcomas is about 25 per 100,000 and 0.7 per 100,000, respectively. Reported risk factors for endometrial cancer are advanced age, unopposed oestrogen stimulation, late menopause, obesity, diabetes mellitus, nulliparity, feminising ovarian tumours, polycystic ovarian syndrome, tamoxifen and belonging to a hereditary non-polyposis colorectal cancer family. Unopposed oestrogen stimulation and tamoxifen have also been confirmed to induce uterine sarcomas. Cervical cytology, endometrial sampling and ultrasound have been proposed in the early diagnosis of endometrial cancer. No pathognomonic ultrasound, magnetic resonance imaging or computed tomography features are able to differentiate between a leiomyoma and a uterine sarcoma, and reliable serum markers for sarcomas are lacking. To date, mass screening for uterine malignancies is not feasible or effective.
ISSN: 1521-6934
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Department of Development and Regeneration - miscellaneous (+)
Gynaecological Oncology
Laboratory of Clinical Immunology
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
screening uterine tumors 2012.pdf Published 154KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science